Expertise in
3
conditions

Israel S. Maia

Florianopolis, SC, BR 
Expertise in
3
conditions
Florianopolis, SC, BR 

Overview

Israel Maia practices practicing medicine in Florianopolis, Brazil.

Mr. Maia is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

He is actively involved in clinical research, co-authoring 67 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Florianopolis, SC, Brazil
Other Locations
Sao Paulo, SP, Brazil
Paraiso, SP 04004030, Brazil
Nereu Ramos, SC, Brazil
Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
Enrollment Status: Terminated
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

65 Total Publications

Susceptibility of large language models to hidden nudge injection during simulated medical peer review: a quasi-experimental study.
Susceptibility of large language models to hidden nudge injection during simulated medical peer review: a quasi-experimental study.
Journal: Research integrity and peer review
Published: February 16, 2026

Frequently Asked Questions about Israel S. Maia

Is Israel S. Maia a top-rated expert for Acute Respiratory Distress Syndrome (ARDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Israel S. Maia is classified as an Advanced expert for Acute Respiratory Distress Syndrome (ARDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Israel S. Maia participate in research or clinical trials?

Yes. Israel S. Maia has published 65 articles and abstracts on conditions like Acute Respiratory Distress Syndrome (ARDS). You can view a list of Israel S. Maia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Maia's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile